Abstract

Plenaries and Special Presentations:Supriya Sharma, Acting Associate Assistant Deputy Minister, Health Canada: "Facing Tomorrow's Regulatory Challenges Today"Mick Bhatia, McMaster Stem Cell and Cancer Research Institute (SCC-RI): "Potential Applications of Human Stem Cells in Therapeutics"You Han Bae, University of Utah: "Current Paradigm of Cancer Nanomedicine and its Perspective - A Gap Between Experimental & Clinical Worlds"Laszlo Endrenyi, University of Toronto: CSPS Lifetime Achievement Award - "Sense and Sensibility (?) in Science"Rav Kumar, GlaxoSmithKline: CSPS Award of Leadership in Canadian Pharmaceutical Sciences - "A Bright Future for Pharmaceutical Sciences in Canada"Emmanuel Ho, University of Manitoba: GlaxoSmithKline/CSPS Early Career Award - "Development of Intravaginal Microbicides for the Prevention of HIV Infection"Building Opportunity Day:- The Life Sciences Industry in Canada: Now and the Future…- Start-up Pharma: Case Studies- Supporting Industry: Funding PanelConference Sessions:1. Early Discovery2. Latest Topics in Bioequivalence3. Successful Candidate Selection from Druggability to Regulatory Submission4. Regulatory Considerations and Analysis of Subsequent Entry Biologics5. Nanomedicine 6. Going Beyond Oral Delivery … Strategies to Enable Drugs to Reach New Targets7. New Trends in Mass Spectrometry for Drug Discovery & Development8. Biomarkers in Pharmacotherapy and Drug Development9. Application of Quality by Design (QbD) and Lifecycle Management to Analytical Procedure10. Current Topics in Drug Safety 11. Recent Trends in Material and Biomaterial Research

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.